Auto-Injector Market Share

North American Market Forecast

Auto-injectors market in North America is predicted to account for the largest share of 45% by 2037 impelled by the rising investment in the healthcare sector. In 2021, healthcare spending made up more than 18% of the country's GDP. The region's advanced healthcare infrastructure encourages more people with a variety of medical problems to use auto-injectors. Recent developments and competitive strategies such as market expansion, mergers and acquisitions, and product launches have been considered to depict a competitive landscape in the market. For instance, in 2023, Coherus BioSciences, Inc. a leading global biosimilar company announced that UDENYCA, a single-dose prefilled auto-injector package, is available for commercial sale which is given the day following chemotherapy to reduce the risk of infection.

APAC Market Statistics

The APAC Auto-injectors market is estimated to be the second largest, during the forecast timeframe led by rising advancement in medical technologies. The 'Make in India' campaign of the Indian government promotes the production of medical devices in the country which has given rise to several advancements and will therefore cause the demand for more sophisticated auto-injectors to skyrocket in the upcoming years that are significant class of medical devices that are self-injectable and capable of delivering medications intramuscularly or subcutaneously.